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Abstract: Malaria continues to be one of the most devastating global health problems due to the high morbidity and 
mortality it causes in endemic regions. The search for new antimalarial targets is of high priority because of the increasing 
prevalence of drug resistance in malaria parasites. Malarial proteases constitute a class of promising therapeutic targets as 
they play important roles in the parasite life cycle and it is possible to design and screen for specific protease inhibitors. In 
this mini-review, we provide a phylogenomic overview of malarial proteases. An evolutionary perspective on the origin 
and divergence of these proteases will provide insights into the adaptive mechanisms of parasite growth, development, 
infection, and pathogenesis. 
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INTRODUCTION  
 Malaria is one of the most important and persistent global 
infectious diseases. It is re-emerging as the number one 
infectious killer, responsible for over one million deaths 
yearly. The causative agents of malaria are a group of 
parasites in the Plasmodium genus. Five species, P. 
falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi 
are human pathogens. P. falciparum causes the most deadly 
form of malaria. 
 The re-emergence of malaria is largely due to the 
growing prevalence of parasite populations that show 
resistance to multiple drug treatment. With the advent of 
high throughput genomic, transcriptomic, proteomic, 
metabolomic, and pharmacogenomic technologies, enormous 
efforts have been focused on the identification and 
characterization of new and effective antimalarial targets [1-
7]. These targets are selected based on several common 
criteria: (1) They are essential for parasite biology. The 
disruption of these genes or gene products leads to 
deleterious effects on parasite growth, development, or 
invasion. For example, cyclin-dependent protein kinases 
(CDKs) play indispensible roles in cell cycle progression and 
signal transduction [8-17]; (2) It is feasible to design or 
screen for effective pharmacophores or candidate inhibitors. 
For example, two compounds, chalcones and tryptanthrins, 
were identified by rational drug design, compound screening 
and molecular modeling as potent and specific inhibitors for  
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the P. falciparum CDK7 homolog, Pfmrk [18]; (3) The drugs 
directed at the selected targets should have no or minimal 
adverse effects on humans. Some of the potential targets 
such as 1-deoxy-D-xylulose 5-phosphate (DOXP) reducto-
isomerase [19, 20] and apicoplast gyrase [21] are localized to 
apicoplast, an organelle uniquely present in Plasmodium 
parasites and other parasites in the Apicomplexa phylum. 
These enzymes are crucial for apicoplast metabolism, 
replication, transcription and translation. Because the 
apicoplast is of prokaryotic origin, the inhibitors of these 
targets may have small or no side effects on the host.  
 Proteases are a class of promising antimalarial targets. 
They are digestive enzymes that degrade peptide bonds. 
They have demonstrated roles in parasite nutrition, 
development, invasion and egress: (1) a cascade of aspartic 
proteases plasmepsins [22, 23], cysteine proteases falcipains 
[24, 25] and metalloproteases [26-28] mediate massive 
degradation of host hemoglobin to release amino acids for 
parasite nutrition; (2) serine proteases (subtilases) have been 
implicated in erythrocyte invasion and parasite exit from the 
host [29-32]; (3) proteases are active mediators for cell cycle 
regulation and cell signaling [33-35]. Because the 
mechanisms of enzymatic action for many classes of 
proteases are known or can be derived from structural 
modeling or computer-aided drug design, it is possible to 
design or screen for protease inhibitors. The inhibitor classes 
for plasmepsins and falcipains have been investigated and 
evaluated [36-44]. 
 Proteases, in addition to their potential as drug targets, 
are a prime example of supergene families with complex 
evolutionary histories involving gene duplication, domain 
shuffling, and lateral gene transfer. In this paper, we present 
a phylogenomic survey of malarial proteases. A better 
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understanding of protease evolution will bring new insights 
into the genetic basis of adaptive phenotypes such as 
pathogenesis and virulence. 
PHYLOGENEOMICS FOR THE IN SILICO PREDI-
CTION OF PROTEASES IN THE PLASMODIUM 
GENOMES 
 Phylogenomics is an emerging discipline that combines 
molecular evolution theory and genomics [45, 46]. One of its 
direct and most important applications is to make functional 
predictions for previously uncharacterized proteins. The 
major hurdle that plagues all genomics-driven efforts in 
antimalarial target identification is the annotation problem 
[47]. In Plasmodium species, sequence similarity can be low, 
due to mutation, insertion, deletion, shuffling and 
recombination events, meaning high-confidence alignments 
between descendant sequences are not feasible and 
functional assignments are obscured. Genome annotation 
using traditional alignment-based algorithms has failed to 
assign functionality to over 60% of the ORFs in P. 
falciparum [48]. Popular methods for building probabilistic 
alignment models, such as PSI-BLAST [49], hidden Markov 
models (HMMs) [50], COMPASS [51] and HHSearch [52] 
show low accuracy and coverage when sequence similarity 
falls below 30% [53-55].  
 Only a handful of proteases had been discovered and 
characterized prior to the completion of genome sequencing 
for P. falciparum [48]. Using a comparative genomic 
approach, we predicted that a total of 92 protease homologs 
were present in P. falciparum genome, and at least 88 of 
them were expressed at the mRNA level by microarray and 
RT-PCR assays [56]. Subsequent data mining on the parasite 
proteome revealed that 67 of these predicted proteases were 
expressed at the protein level at least in one stage of the life 
cycle [57]. Recently we extended our study to other sibling 
species of malaria parasites, including P. vivax [58], which is 
the most widely distributed human malaria parasite, and 
three rodent species P. berghei, P. chabaudi, and P. yoelii 
yoelii [59, 60], which serve as the animal models for human 
malaria. In addition to traditional BLAST searches, we 
adopted a novel support vector machine (SVM)-based, 
supervised machine learning approach to tackle the remote 
homology problem. The underlying principle for remote 
homology detection lies in the domain of phylogenomics: 
these algorithms are designed to capture subtle similarities 
between the unknown proteins and the annotated proteins 
based on the evolutionarily conserved characteristics of the 
genes/proteins. A SVM classifier is a function that separates 
the training data into two classes and also maximizes the 
geometric margin between them in a feature space. Unlike 
most alignment-based algorithms which build models only 
with positive sequences, SVMs also use negative sequences 
(proteins outside the protein family) to learn the difference 
between the two classes. The SVM approach discovered 
several putative proteases that were not detectable by PSI-
BLAST. For example, one putative PPPDE protease 
(PFI0940c) is a member of a novel family with a papain-like 
fold. This family was postulated to play a role in 
deubiquitination and cell cycle regulation [61]. The total 
number of predicted proteases in P. falciparum was 
increased from 92 to 123.  
 The degradome of five malaria parasite species is 
comprised of 115-137 putative proteases in five distinct 
catalytic classes (aspartic, cysteine, metallo, serine and 
threonine) (See Table 2 and Table 3 in [47]), which account 
for 0.9-2.3% of the open reading frames (ORFs) in the 
genome. They form 37 protein families based on their 
evolutionary relationship and structure conservation, 
according to the MEROPS protease classification system 
[62], and 29 of these families are commonly shared in five 
species. These proteases are important players in 
metabolism, cell cycle regulation, invasion, stress response, 
transcriptional regulation, signal transduction, and 
trafficking. A number of these proteases are becoming 
targets for functional characterization and rational inhibitor 
design [43, 63-69].  
PHYLOGENOMICS FOR FUNCTIONAL CHARAC-
TERIZATION OF MALARIAL PROTEASES 
 Phylogenomic analysis provides a cost-effective means 
to examine the evolutionary profiles of genes and gene 
products for functional prediction or characterization. The 
procedure often involves homology identification, multiple 
sequence alignment, phylogenetic reconstruction, inference 
of function, evolutionary analysis of orthology and paralogy, 
and identification of lateral gene transfer events [70]. This 
approach is particularly useful for the studies of protein 
families and protein superfamilies such as kinases and 
transporters [71-74]. In the domain of protease researches, 
phylogenomics has contributed to, for example, the 
classification and reconstruction of evolutionary diversi-
fication of serine proteases in fungi [75], the evolutionary 
profiling of cystatins, which comprise a superfamily of 
cysteine protease inhibitors [76], and the development of a 
statistical framework that was able to detect site-specific 
functional divergence in the caspase family of cysteine 
proteases [77]. The annotation of the predicted malarial 
proteases was essentially based on phylogenomic analysis 
[56], which revealed an array of novel proteases that could 
potentially be important for parasite-specific functions. A 
single copy of calpain was identified in the five surveyed 
Plasmodium genomes. It contains active site residues 
(C1035-N-1371-H1391 in P. falciparum) that are conserved 
in known or characterized calpains. Although calpains are 
well-known modulators for signal transduction, differen-
tiation, cell motility, cell cycle regulation and cell-cell 
communication from bacteria to humans, its physiological 
role in parasite biology is yet to be defined. Nevertheless, 
partial knockdown assays indicated that the malarial calpain 
is crucial for the optimal growth of the parasite and cell cycle 
progression [78]. Interestingly, phylogenetic analysis 
revealed that the malarial calpain belongs to a clade of 
calcium-independent calpains, a lineage restricted to 
alveolates; the divergence from major human calpains makes 
it a possible drug target.  
 Multiple copies of metacaspases were identified in 
Plasmodium genomes [34, 47, 79], suggesting the existence 
of apoptosis or a similar signaling cascade in malaria 
parasites. Apoptosis-inducer and the administration of 
antimalarial drug chloroquine were shown to lead to DNA 
fragmentation and mitochondrial membrane potential 
disruption, indicative of the onset of programmed cell death 


















Fig. (1). The phylogenetic tree of metacaspases in Plasmodium, inferred using the neighbor-joining method based on the amino acid 
sequences with Poisson corrected distance [111]. Evolutionary analyses were conducted in MEGA5 [112]. The option of complete deletion of 
gaps was used for tree construction. 1,000 bootstrap replicates were used to infer the reliability of branching points. Bootstrap values of >50% 
are presented. The scale bar indicates the number of amino acid substitutions per site. The abbreviations for species names are: Pf: P. 
falciparum; PKH: P. knowlesi; PVX: P. vivax; PBNKA: P. berghei ANKA; PCHAS: P. chabaudi AS; PY: P. yoelli yoelii. 
in the parasite [80]. Phylogenetic analysis shows that this 
family may be generated by at least one gene duplication 
event: metacaspase-3 may represent an ancestral form, while 
metacaspase-1 and metacaspase-2 are more closely related to 
each other (Fig. 1). Metacaspase-1, in particular, contains the 
typical catalytic domain and the active site residues 
(histidine and cysteine dyad) that are essential for proteolytic 
function. In addition, it harbors a caspase recruitment 
domain (CARD) for apoptosis-related signaling [80]. The 
discovery of metacaspases has triggered the search for 
proteins/regulators in the parasite apoptotic network [81], 
which may represent a major stress-response system for 
parasites to survive under drug treatment and host immune 
challenges. Another example of potentially important 
proteases in malaria parasites is the signal peptide peptidase 
(SPP). SPP is an active player in regulated intramembrane 
proteolysis (RIP), which initiates signal transduction via 
processing the transmembrane segments of the substrates. 
One single copy of SPP is found in P. falciparum, P. vivax, 
P. yoelii yoelii, and P. chabaudi, and two copies are present 
in P. berghei. The putative active sites Tyr–Asp (YD) and 
Gly–Leu–Gly–Asp (GLGD) motifs which are universally 
conserved in SPPs are present in all the malarial SPPs (Fig. 
2A). Phylogenetic analysis shows that the malarial SPPs 
form a distinct clade that is distantly related to the SPPs 
found in other animals from the fruit fly to the human (Fig. 
2B). Data mining of the protein-protein interaction network 
revealed that P. falciparum SPP (PfSPP) is a highly 
connected protein with 54 association partners. Fig. (3) 
shows a schematic association map of PfSPP with 
representative partners with relatively high statistical 
support. Each association between a pair of proteins has a 
confidence score (S) ranging from 0.15 to 0.999 that was 
inferred from the evidence used to establish the association 
[82], including the interolog comparisons, which is rooted on 
phylogenomic inference of network associations among 
evolutionarily related organisms, yeast-2-hybrid (Y2H) 
assays, Gene Ontology (GO) classification for biological 
functions, cellular processes and sublocations, structural 
configuration, co-expression and co-occurrence patterns, and 
so on [83, 84]. Phylogenomic inference predicted that PfSPP 
is associated with a putative ER lumen protein retaining 
receptor (ERD2) [85] and a secretory protein Sec61 [86], 
both of which are components in the parasite translocation 
machinery required for the uptake of nutrients and expulsion 
of wastes: the SPP homolog was found to be co-expressed 
with the ERD2 and Sec61 homologs in three model 
organisms: Arabidopsis thaliana, Caenorhabditis elegans, 
and Drosophila melanogaster. PfAPP is also associated with 
signal peptidase, translation initiation and elongation factors, 
splicing factor, peptide chain release factor, and a variety of 
enzymes, suggesting that it is involved in transport, 
translation, posttranslational regulation and metabolism. It 
has recently been considered as a promising drug target since 
gene disruption assays indicate it is essential for parasite 
growth and merozoite invasion [87, 88]. 
PHYLOGENOMICS FOR ASSESSING THE SUITABI-
LITY OF MALARIAL PROTEASES AS DRUG TAR-
GETS  
 Phylogenomic analysis can reveal the complex 









































































Fig. (2). (A) The alignment of the catalytic region of the signal peptide peptidases (SPPs) in six Plasmodium species and other representative 
species. The putative active sites Tyr–Asp (YD) and Gly–Leu–Gly–Asp (GLGD) motifs are highlighted. (B) The phylogenetic tree of SPPs, 
inferred using the neighbor-joining method based on the amino acid sequences with Poisson corrected distance. 
(A)                                                                                                                                                        
marmoset       145 GSGENKEEIVNYEFDTKDLVCLGLSSIVGVWYLLRKHWIANNLFGLAFSLNGVELLHLNNVSTGCILLGGLFIYDVFWVF 
human          145 GSGENKEEIINYEFDTKDLVCLGLSSIVGVWYLLRKHWIANNLFGLAFSLNGVELLHLNNVSTGCILLGGLFIYDVFWVF 
dog            145 GSGENKEEIINYEFDAKDLVCLGLSSIVGVWYLLRKHWIANNLFGLAFSLNGVELLHLNNVSTGCILLGGLFIYDVFWVF 
rabbit         145 GSGENKEEIINYEFDTKDLVCLGLSSIVGVWYLLRKHWIANNLFGLAFSLNGVELLHLNNVSTGCILLGGLFIYDVFWVF 
mouse          145 GSGENKEEIINYEFDTKDLVCLGLSSVIGVWYLLRKHWIANNLFGLAFSLNGVELLHLNNVSTGCILLGGLFIYDIFWVF 
rat            145 GSGENKEEIINYEFDTKDLVCLGLSSVVGVWYLLRKHWIANNLFGLAFSLNGVELLHLNNVSTGCILLGGLFIYDIFWVF 
opossum        150 GSGENKEEIVNYEFDSKDLVCLTLSSVIGVWYLLRKHWIANNLFGLAFSLNGVELLHLNNVSTGCILLGGLFVYDIFWVF 
frog           143 GSGESKEEIVNYEFDTRDLVCLVLSGVVGVWYLLKKHWIANNLFGLAFSLNGVELLHLNNVSTGCILLGGLFVYDIFWVF 
salmon         160 GSGETKEEIVNYEFDTKDMICLVISTVVGVWYILKKHWIANNLFGLAFALNGVELLHLNNVSTGCILLGGLFVYDVFWVF 
fruit fly      154 GEGKHKEDIVNYKFSTHDIVCLVISSAIGVWYLLKKHWIANNLFGLAFAINGVEMLHLNNFVTGVILLSGLFFYDIFWVF 
PVX_117615     157 PGFISKEPVI-FNTNKGEIISFLFCFFIGARWIFYKDFITHNVLAVSFCFQAISLVILSNFLIGFLLLSGLFVYDIFWVF 
PKH_124910     157 PGFISKEPVV-FNTNKGEIISFLVCFFIGGRWIFYKDFITHNVLAVSFCFQAISLVILSNFLIGFLLLSGLFVYDIFWVF 
PF14_0543      155 PNFIYKEPIV-FNTNKGEIVCLILSFAIGLRWIFYKDFITHNVLAVSFCFQAISLVILSNFLIGFLLLSGLFVYDIFWVF 
PBANKA_132070  149 PKFISKDPIV-FNTNKGEIMSLIVCFIIGARWIFYKDFVTHNILAISFCFQALSLVILSNFVIGFILLSGLFVYDIFWVF 
PY06507          1 -------PIV-FNTNKGEIMSLIVCFIIGARWIFYKDFITHNILAISFCFQALSLVILSNFVIGFILLSGLFVYDIFWVF 
PCHAS_132400   149 PKFISKDPIV-FNTNKGEILSLIVCFIIGARWLFYKDFITHNILAISFCFQALSLVILSNFVIGFILLSGLFVYDIFWVF 
consensus      161 gsge keeivnyefdtkdlvclvlssiiGvwyllrKhwianNlfglaFslngvellhLnNvstGciLLgGLFvYDiFWVF 
                                                      
                                                             
marmoset       225 GTNVMVTVAKSFEAPIKLVFPQDLLEKGLEADNFAMLGLGDIVIPGIFIALLLRFDISLKKN------------------ 
human          225 GTNVMVTVAKSFEAPIKLVFPQDLLEKGLEANNFAMLGLGDVVIPGIFIALLLRFDISLKKN------------------ 
dog            225 GTNVMVTVAKSFEAPIKLVFPQDLLEKGLEADNFAMLGLGDIVIPGIFIALLLRFDISLKKN------------------ 
rabbit         225 GTNVMVTVAKSFEAPIKLVFPQDLLEKGLEADNFAMLGLGDIVIPGIFIALLLRFDISLKKN------------------ 
mouse          225 GTNVMVTVAKSFEAPIKLVFPQDLLEKGLEADNFAMLGLGDIVIPGIFIALLLRFDISLKKN------------------ 
rat            225 GTNVMVTVAKSFEAPIKLVFPQDLLEKGLEADNFAMLGLGDIVIPGIFIALLLRFDISLKKN------------------ 
opossum        230 GTNVMVTVAKSFEAPIKLVFPQDLLEKGLEADNFAMLGLGDIVIPGIFIALLLRFDISLKKN------------------ 
frog           223 GTNVMVTVAKSFEAPIKLVFPQDLLEKGLEANNFAMLGLGDIVIPGIFIALLLRFDVSLKKN------------------ 
salmon         240 GTNVMVTVAKSFEAPIKLVFPQDLFEKGLGANQFAMLGLGDIVIPGIFIALLLRFDVSLKKN------------------ 
fruit fly      234 GTNVMVTVAKSFEAPIKLVFPQDLIENGLNASNFAMLGLGDIVIPGIFIALLLRFDDSKKRK------------------ 
PVX_117615     236 GNDVMVTVAKSFEAPVKLLFP-----VSKDPVHYSMLGLGDIIIPGIVISLCLRFDYYLHRNKIHKGNFKKMFNDISIHE 
PKH_124910     236 GNDVMVTVAKSFEAPVKLLFP-----VSTDPVHYSMLGLGDIIIPGIVISLCLRFDYYLHRNKIHKGNFKKMFNDISIHE 
PF14_0543      234 GNDVMVTVAKSFEAPVKLLFP-----VSSDPVHYSMLGLGDIIIPGILMSLCLRFDYYLFKNNIHKGNLKKMFNDISIHE 
PBANKA_132070  228 GNDVMVTVAKSFEAPVKLLFP-----VSLDPLHYSMLGLGDIIIPGILISLCLRFDYYLHRNKIHKGNVKKMFNDISIHE 
PY06507         73 GNDVMVTVAKSFEAPVKLLFP-----VSLDPLHYSMLGLGDIIIPGILISLCLRFDYYLHRNKIHKGNVKKMFNDISIHE 
PCHAS_132400   228 GNDVMVTVAKSFEAPVKLLFP-----VSLDPLHYSMLGLGDIIIPGILMALCLRFDYYLHRNKIHKGNTKKMFNDISIHE 
consensus      241 GtnVMVTVAKSFEAPiKLvFPqdllekglea nfaMLGLGDivIPGIfiaLlLRFDislkkn                   
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Fig. (3). The protein-protein association map of Plasmodium falciparum SPP. The association partners were predicted by STRING [84]. This 
set of associations can be visualized in Cytoscape [113] and converted to an undirected weighted graph. Confidence scores for the interactions 
among the nodes (S values from STRING) were divided into three groups - low (0.150-0.399), medium (0.400-0.700) and high (0.701-0.999); 
the groups are represented by thin, medium and heavy lines, respectively. 
relatedness to the host help researchers to assess their 
suitability as potential antimalaria targets. Jean et al. [89] 
and Coombs et al. [22] conducted elegant phylogenomic 
analyses on plasmepsins, a group of aspartic proteases in the 
pepsin (A1) family. Ten plasmepsins have been identified in 
P. falciparum, namely PM I-X; PM III is also known as 
histo-aspartic protease (HAP). They are divided into two 
classes (Fig. 4): (1) PM I-IV are all intronless with one 
single exon; They are located in adjacent positions on 
Chromosome 14, and are likely to be generated by tandem 
gene duplications. (2) PM V-X form a large clade which 
may represent an ancestral type of plasmepsins; Introns are 
present in PM VI, VII, VIII, and IX. The most extreme case 
is seen in PM VI, which contains 15 exons. An evolutionary 
model suggested that lateral gene transfer, exon shuffling 
and intron loss events may lead to the diverse types of 
plasmepsins in the parasite genome that are required for 
effective hemoglobin digestion [22, 89]. Inhibition of 
hemoglobin digestion causes starvation of the parasite and 
accumulation of intermediates toxic to parasites [23, 90]. 
Recently, two neutral aminopeptidases, M1 alanyl 
aminopeptidase (PfM1AAP, MAL13P1.56) and M17 leucine 
aminopeptidase (PfM17LAP, PF14_0439) have been 
characterized. Both enzymes are required for the late stage of 
hemoglobin digestion, which releases free amino acids for 
parasite nutrition and development inside the human red 
blood cell. Parasites were not viable in vivo and in vitro with 
the treatment of aminopeptidase inhibitors [91]. Because 
only single copy of PfM17LAP is present in P. falciparum 
genome, its disruption cannot be compensated for by any 
homolog. The X-ray structure of PfM17LAP has been 
resolved, opening a promising avenue for rational drug 
design [92].  
 Gene duplication and lateral gene transfer are implicated 
in the evolution of other protease families such as subtilases 
and falcipains. Three copies of subtilases are found in P. 
falciparum genome and 2-5 copies are present in the other 
Plasmodium genomes. Subtilases are required for parasite 
invasion and egress from the human host [30, 93-95]. 
Evolutionarily, they are probably acquired via lateral gene 
transfer from a bacteria origin where subtilsins are 
commonly found. No statistically significant subtilase 
homologs are found in the humans, which is a desirable 
feature for drug targets. Similarly, falcipains are crucial for 
parasite biology; they may have dual roles in both 
hemoglobin digestion and host cell egress [30, 96-98]. They 
are evolutionarily closely related to the papains found in 
viruses and fungi. Lineage-specific expansion is evident in 
the evolution of rhomboid proteases (the S54 serine protease 
family) in Plasmodium: eight copies are present in P. 
falciparum, and 5-8 copies are present in the other species. 
They are the central players in regulated intramembrane 
proteolysis (RIP) and have been implicated in parasite 
development, invasion, cell signaling and pathogenesis [35, 
99-101]. Different rhomboid proteases may have specific 
substrates preferences; their potential substrates include 
various adhesins and surface antigens [33]. Phylogenetic 
analysis revealed that they are closely related to the 
rhomboid homologs present in other apicomplexan parasites 
including Toxoplasma gondii, Eimeria tenella, 
422    Current Genomics, 2011, Vol. 12, No. 6 Cai et al. 
Cryptosporidium spp. and Theileria spp [102]. There is only 
weak sequence similarity between the malarial rhomboids 
and a mitochondrial rhomboid protease, PARL, in the human 
genome. Targeting rhomboids and their associated signaling 
pathways therefore may be a novel therapeutic strategy. 
Other proteases with potentially important functions, such as 
calpain, metacaspases, and signal peptidase I, are also 
phylogenetically divergent from the host lineage. 
 Phylogenomic analysis also revealed a group of putative 
malarial proteases that are destined to parasite-specific 
organelles of prokaryotic origin. The top target organelle for 
drug development is the apicoplast. It is essential for parasite 
life cycle, as inhibitors for apicoplast metabolism and 
replication resulted in the death of parasite [103, 104]. Using 
two independent algorithms, PATS (an artificial neural 
network algorithm) [105] and PlasmoAP [106], which 
combines signal peptide prediction [107] and rule-based 
classification, Ralph et al. [104] identified more than 540 
genes in P. falciparum that are targeted to the apicoplast. 
Twenty-one of these genes encode putative proteases (Table 
1). Because the apicoplast is derived from an ancient 
endosymbiosis in which the eukaryotic ancestor engulfed a 
red alga with a solitary chloroplast, its disruption does not 
cause significant interference with the host functions. The 
cyanobacterial heritage of the apicoplast enhances the 
potential of these apicoplast-targeted proteases as drug 
targets. Notably, five putative proteases from the ClpP 
endopeptidase family (S14) are predicted to be localized to 
the apicoplast (Table 1). They are the central players in the 






























Fig. (4). The phylogenetic tree of plasmpepsins, inferred using the neighbor-joining method based on the amino acid sequences with Poisson 
corrected distance. PM I-IV contain one single exon without any introns. PM VI contains 15 exons, PM VIII contains 13 exons, PM VII and 
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parasite adaptation to host environment, which involves a 
transmission from the Anopheles gambiae mosquito (~25°C) 
to the human host (~37°C), and the host's recurrent fever 
caused by infection. Fig. (5) shows a protein-protein 
association map of a putative Clp protease, PF11_0175. It is 
associated with various heat shock proteins (HSPs) including 
HslV (PFL1465c), an ATP-dependent threonine protease, 
Hsp60 (PF10_0153), Hsp70 homologs (PF11_0351, 
PF08_0054, PFI0875w, and MAL7P1.228), Hsp 90 
(PF07_0029), Hsp40 (PFB0595w), a putative small Hsp 
(PF13_0021), a chaperonin cpn10 (PFL0740c), a putative 
Hsp70/Hsp90 organizing protein (PF14_0324), and a co-
chaperone GrpE(PF11_0258). Inhibition assays showed that 
the Clp proteases and the chaperone HSPs are essential for 
parasite growth and development [108, 109]. It is possible to 
design inhibitors targeting specifically for malarial Clp 
proteases as the selective inhibitors for the ClpP protease 
complex has been developed in the bacteria system in 
Staphylococcus aureus [110]. 
CONCLUSIONS 
 The phylogenomic approach has played an important role 
in the identification and in silico characterization of 
proteases in malaria parasites, providing a promising and 
largely uncharacterized set of targets for wet lab functional 
characterization and drug design. An evolutionary 
perspective on the origin and divergence of these proteases 
provides insights into the adaptive mechanisms of parasite 
growth, development, infection, and pathogenesis.  
Table 1. Putative Proteases that are Predicted to Localize to the Apicoplast in P. falciparum 
Catalytic Type Protease Family P. falciparum protease ID Annotation 
PF13_0133 Plasmepsin V 
A1 (pepsin family) 
PF14_0625 Plasmepsin VIII Aspartic 
A22 (presenilin family) PF14_0543 signal peptide peptidase 
Cysteine C1 (papain family) PFD0230c dipeptidyl peptidase 3 
M1 (aminopeptidase N family) MAL13P1.56 
M1-family alanyl aminopeptidase 
AMPN  
M16 (pitrilysin family) PF14_0382 Pitrilysin 
M17 (leucyl aminopeptidase family) PF14_0439 M17 leucyl aminopeptidase 
MAL8P1.140 putative methionine aminopeptidase 1c 
M24 (methionyl aminopeptidase 1) 
PF14_0517 aminopeptidase P 
Metallo 
M41 (FtsH endopeptidase family) PF14_0616 putative ATP-dependent protease la 
S8 (subtilisin family) PFE0355c putative subtilisin-like protease 3 
PFC0310c 
ATP-dependent Clp protease proteolytic 
subunit 
PF14_0348 
ATP-dependent Clp protease proteolytic 
subunit 
PF08_0063 putative ClpB 
PF14_0063 putative ATP-dependent Clp protease 
S14 (ClpP endopeptidase family) 
PF11_0175 Clp protease, heat shock protein 101 
PFC0065C putative alpha/beta hydrolase 
S33 (prolyl aminopeptidase) 
PF14_0015 putative aminopeptidase 
MAL8P1.16 rhomboid protease ROM3 
Serine 
S54 (Rhomboid family) 
PF13_0312 rhomboid protease ROM7 
Unknown U48 (prenyl protease 2 family) PFI0660c putative protease 
 
Fig. (5). The protein-protein association map of PF11_0175, a 
putative Clp protease in P. falciparum.  
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